The major concern of pharmacology about cytokines has originated from plentiful data showing association between gross changes in their production and pathophysiological processes. Despite the enigmatic role of cytokines in diseases, a number of them have become a subject of cytokine and anti-cytokine immunotherapies. Production of cytokines can be influenced by many endogenous and exogenous stimuli including drugs. Cells of the immune system, such as macrophages and lymphocytes, are richly endowed with receptors for the mediators of physiological functions, such as biogenic amines, adenosine, prostanoids, steroids, etc. Drugs, agonists or antagonists of these receptors can directly or indirectly up- and down-regulate secretion of cytokines and expression of cytokine receptors. Vice versa, cytokines interfere with drug pharmacokinetics and pharmacodynamics through the interactions with cytochrome P450 and multiple drug resistance proteins. The aim of the review is to encourage more intensive studies in these fields of cytokine pharmacology. It also outlines major areas of searching promising candidates for immunotherapeutic interventions.

Department of Pharmacology Institute of Experimental Medicine Academy of Sciences of the Czech Republic v v i Vídenská 1083 142 20 Prague 4 Czech Republic

Zobrazit více v PubMed

Abbracchio MP, Ceruti S. P1 receptors and cytokine secretion. Purinergic Signal. 2007;3:13–25. PubMed PMC

Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, et al. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol. 1993;44:707–715. PubMed

Abdel-Razzak Z, Corcos L, Fautrel A, Campion JP, Guillouzo A. Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture. Mol Pharmacol. 1994;46:1100–1110. PubMed

Adam L, Black PC, Kassouf W, Eve B, McConkey D, Munsell MF, et al. Adenoviral mediated interferon-alpha 2b gene therapy suppresses the pro-angiogenic effect of vascular endothelial growth factor in superficial bladder cancer. J Urol. 2007;177:1900–1906. PubMed

Adams DH, Lloyd AR. Chemokines: leucocyte recruitment and activation cytokines. Lancet. 1997;349:490–495. PubMed

Aitken AE, Lee CM, Morgan ET. Roles of nitric oxide in inflammatory downregulation of human cytochromes P450. Free Radic Biol Med. 2008;44:1161–1168. PubMed PMC

Akaza H, Tsukamoto T, Onishi T, Miki T, Kinouchi T, Naito S. A low-dose combination therapy of interleukin-2 and interferon-α is effective for lung metastasis of renal cell carcinoma: a multicener open study. Int J Clin Oncol. 2006;11:434–440. PubMed

Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B, et al. Phenotypic and functional features of human Th17 cells. J Exp Med. 2007;204:1849–1861. PubMed PMC

Arad G, Nussinovich R, Na'amad M, Kaempfer R. Dual control of human interleukin-2 and interferon-g gene expression by histamine: activation and suppression. Cell Immunol. 1996;170:149–155. PubMed

Asres K, Seyoum A, Veeresham C, Bucar F, Gibbons S. Naturally derived anti-HIV agents. Phytother Res. 2005;19:557–581. PubMed

Assenat E, Gerbal-Chaloin S, Larrey D, Saric J, Fabre JM, Maurel P, et al. Interleukin 1β inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance. Hepatology. 2004;40:951–960. PubMed

Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, et al. Expression and secretion of by β transforming growth factor by activated human macrophages. Proc Natl Acad Sci U S A. 1987;84:6020–6024. PubMed PMC

Bach EA, Aguet M, Schreiber RD. The IFNγ receptor: a paradigm for cytokine receptor signaling. Annu Rev Immunol. 1997;15:563–591. PubMed

Bambust I, Van Aelst F, Joosens E, Schallier D, Rezaei Kalantari H, Paulus R, et al. A Belgian registry of interleukin-2 administration for treatment of metastatic renal cell cancer and confrontation with literature data. Acta Clin Belg. 2007;62:223–229. PubMed

Bani MR, Garofalo A, Scanziani E, Giavazzi R. Effect of interleukin-1-β on metastasis formation in different tumor systems. J Natl Cancer Inst. 1991;83:119–123. PubMed

Bani S, Gautam M, Sheikh FA, Khan B, Satti NK, Suri KA, et al. Selective Th1 up-regulating activity of Withania somnifera aqueous extract in an experimental system using flow cytometry. J Ethnopharmacol. 2006;107:107–115. PubMed

Beck J, Rondot P, Catinot L, Falcoff E, Kirchner H, Wietzerbin J. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand. 1988;78:318–323. PubMed

Belliard AM, Lacour B, Farinotti R, Leroy C. Effect of tumor necrosis factor-alpha and interferon-gamma on intestinal P-glycoprotein expression, activity, and localization in Caco-2 cells. J Pharm Sci. 2004;93:1524–1536. PubMed

Belliard AM, Tardivel S, Farinotti R, Lacour B, Leroy C. Effect of hr-IL2 treatment on intestinal P-glycoprotein expression and activity in Caco-2 cells. J Pharm Pharmacol. 2002;54:1103–1109. PubMed

Bermel RA, Rudick RA. Interferon-β treatment for multiple sclerosis. Neurotherapeutics. 2007;4:633–646. PubMed PMC

Beuscher HU, Günther C, Röllinghoff M. IL-1β is secreted by activated murine macrophages as biologically inactive precursor. J Immunol. 1990;144:2179–2183. PubMed

Bhatia M, Landolfi C, Basta F, Bovi G, Ramnath RD, de Joannon AC, et al. Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis. Inflamm Res. 2008;57:464–471. PubMed

Biju P, Taveras A, Yu Y, Zheng J, Chao J, Rindgen D, et al. 3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists. Bioorg Med Chem Lett. 2008;18:228–231. PubMed

Blick SK, Curran MP. Certolizumab pegol: in Crohn's disease. BioDrugs. 2007;21:195–201. PubMed

de Boer WI. Perspectives for cytokine antagonist therapy in COPD. Drug Discov Today. 2005;10:93–106. PubMed

Brunner T, Heusser CH, Dahinden CA. Human peripheral blood basophils primed by interleukin-3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med. 1993;177:605–611. PubMed PMC

Carlson TJ, Billings RE. Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450. Mol Pharmacol. 1996;49:796–801. PubMed

Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A review of the multiple actions of melatonin on the immune system. Endocrine. 2005;27:189–200. PubMed

Casilli F, Bianchini A, Gloaguen I, Biordi L, Alesse E, Festuccia C, et al. Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2. Biochem Pharmacol. 2005;69:385–394. PubMed

Cassatella MA, Gasperini S, Bovolenta C, Calzetti F, Vollebregt M, Scapini P, et al. Interleukin-10 (IL-10) selectively enhances CIS3/SOCS3 mRNA expression in human neutrophils: evidence for an IL-10-induced pathway that is independent of STAT protein activation. Blood. 1999;94:2880–2889. PubMed

Chao CC, Hu S, Sheng WS, Tsang M, Peterson PK. Tumor necrosis factor-α mediates the release of bioactive transforming growth factor-β in microglial cell cultures. Clin Immunol Immunoptahol. 1995;77:358–365. PubMed

Cheng AC, Stephens DP, Currie BJ. Granulocyte-colony stimulating factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adluts. Cochrane Database Syst Rev. 2007;2:CD004400. PubMed

Cherney RJ, Mo R, Meyer DT, Nelson DJ, Lo YC, Yang G, et al. Discovery of disubstituted cyclohexanes as a new class of CC chemokine receptor 2 antagonists. J Med Chem. 2008;51:721–724. PubMed

Clark R. Pegasys® (peginterferon alfa-2a [40 kDa]) Drugs Cont. 2007;3:65–83.

Clerici M, Shearer GM. A Th1 to Th2 switch is a critical step in the etiology of HIV infection. Immunol Today. 1992;14:107–111. PubMed

Clerico M, Contessa G, Durelli L. Interferon-β1a for the treatment of multiple sclerosis. Expert Opin Biol Ther. 2007;7:535–542. PubMed

Cloëz-Tayarani I, Changeux JP. Nicotine and serotonin in immune regulation and inflammatory processes: a perspective. J Leukoc Biol. 2007;81:599–606. PubMed

Condie RC, Herring A, Koh WS, Lee M, Kaminski NE. Cannabinoid inhibition of adenylate-mediated signal transduction and IL-2 expression in the murine T-cell line, EL4.IL-2. J Biol Chem. 1996;271:13175–13183. PubMed

Cooksley WG, Piratvisuth T, Lee SD, Mahachai V, Chao YC, Tanwandee T, et al. Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B. J Viral Hepat. 2003;10:298–305. PubMed

Corcos M, Guilbaud O, Hjalmarsson L, Chambry J, Jeammet P. Cytokines and depression: an analogic approach. Biomed Pharmacother. 2002;56:105–110. PubMed

Cottone M, Orlando A, Modesto I. Postoperative maintenance therapy for inflammatory bowel disease. Curr Opin Gastroenterol. 2006;22:377–381. PubMed

Cousins DJ, Staynov DZ, Lee TH. Regulation of interleukin-5 and granulocyte-macrophage colony-stimulating factor expression. Am J Respir Crit Care Med. 1994;150:S50–S53. PubMed

Cowan MM. Plant products as antimicrobial agents. Clin Microbiol Rev. 1999;12:564–582. PubMed PMC

Crawford JH, Yang S, Zhou M, Simms HH, Wang P. Down-regulation of hepatic CYP1A2 plays an important role in inflammatory responses in sepsis. Crit Care Med. 2004;32:502–508. PubMed

Cross ML, Ganner A, Teilab D, Fray LM. Patterns of cytokine induction by gram-positive and gra-negative probiotic bacteria. FEMS Immunol Med Microbiol. 2004;42:173–180. PubMed

Dalpke A, Zimmermann S, Heeg K. CpG DNA in the prevention and treatment of infections. BioDrugs. 2002;16:419–431. PubMed

Damaskos D, Kolios G. Probiotics and prebiotics in inflammatory bowel disease: microflora ‘on the scope. Br J Clin Pharmacol. 2008;65:453–467. PubMed PMC

Danese S, Semeraro S, Armuzzi A, Papa A, Gasbarrini A. Biological therapies for inflammatory bowel disease: research drives clinics. Mini Rev Med Chem. 2006;6:771–784. PubMed

Defilippi P, Poupart P, Tavernier J, Fiers W, Content J. Induction and regulation of mRNA encoding 26-kDa protein in human cell lines treated with recombinant human tumor necrosis factor. Proc Natl Acad Sci U S A. 1987;84:4557–4561. PubMed PMC

Delaporte E, Renton KW. Cytochrome P4501A1 and cytochrome P4501A2 are downregulated at both transcriptional and post-trenascriptional levels by conditions resulting in interferon-alpha/beta induction. Life Sci. 1997;60:787–796. PubMed

Denton CP, Merkel PA, Furst DE, Khanna D, Emery P, Hsu VM, et al. Recombinant human anti-transforming growth factor beta1 antibody therapy in systemic sclerosis: a multicenter, randomized, placebo-controlled phase I/II trial of CAT-192. Arthritis Rheum. 2007;56:323–333. PubMed

Descotes J. Immunomodulating agents and hepatic drug-metabolizing enzymes. Drug Metab Rev. 1985;16:175–184. PubMed

Devalaraja MN, Richmond A. Multiple chemotactic factors: fine control or redundancy? TIPS. 1999;20:151–156. PubMed

Di Stefano A, Paulesu L. Inhibitory effect of melatonin on production of IFN gamma or TNF alpha in peripheral blood mononuclear cells of some blood donors. J Pineal Res. 1994;17:164–169. PubMed

Dinarello CA. Blocking IL-1 in systemic inflammation. J Exp Med. 2005;201:1355–1359. PubMed PMC

Diwanay S, Chitre D, Patwardhan B. Immunoprotection by botanical drugs in cancer chemotherapy. J Ethnopharmacol. 2004;90:49–55. PubMed

Dixit SG, Zingarelli B, Buckley DJ, Buckley AR, Pauletti GM. Nitric oxide mediates increased P-glycoprotein activity in interferon-γ-stimulated human intestinal cells. Am J Physiol Gastrointest Liver Physiol. 2005;288:G533–G540. PubMed

Dogusan Z, Hooghe-Peters EL, Berus D, Velkeniers B, Hooghe R. Expression of SOCS genes in normal and leukemic human leukocytes stimulated by prolactin, growth hormone and cytokines. J Neuroimmunol. 2000;109:34–39. PubMed

Dutcher J. Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma. Oncology (Williston Park) 2002;16(Suppl.)(13):4–10. PubMed

Ebnet K, Vestweber D. Molecular mechanisms that control leukocyte extravasation: the selectins and the chemokines. Histochem Cell Biol. 1999;112:1–23. PubMed

Eisle B, von Henneicke H-H. Soluferon®– a 2nd generation interferon-β with increased bioavailability (Abstract) J Interferon Cytokine Res. 2007;27:703.

El-Obeid A, Al-Harbi S, Al-Jomah N, Hassib A. Herbal melanin modulates tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6) and vascular endothelial growth factor (VEGF) production. Phytomedicine. 2006;13:324–333. PubMed

Elenkov IJ. Glucocorticoids and the Th1/Th2 balance. Ann N Y Acad Sci. 2004;1024:138–146. PubMed

Elkahwaji J, Robin MA, Berson A, Tinel M, Lettéron P, Labbe G, et al. Decrease in hepatic cytochrome P450 after interleukin-2 immunotherapy. Biochem Pharmacol. 1999;57:951–954. PubMed

Fan P-T, Leong K-H. The use of biological agents in the treatment of rheumatoid arthritis. Ann Acad Med Singapore. 2007;36:128–134. PubMed

Farquhar D, Loo TL, Gutterman JU, Hersh EM, Luna MA. Inhibition of drug-metabolizing enzymes in the rat after Bacillus Calmette-Guérin treatment. Biochem Pharmacol. 1976;25:1529–1535. PubMed

Fernandez C, Buyse M, German-Fattal M, Gimenez F. Influence of the pro-inflammatory cytokines on P-glycoprotein expression and functionality. J Pharm Pharmaceut Sci. 2004;7:359–371. PubMed

Ferretti S, Bonneau O, Dubois GR, Jones CE, Trifilieff A. IL-17, produced by lymphocytes and neutrophils, is necessary for lipopolysaccharide-induced airway neutrophilia: IL-15 as a possible trigger. J Immunol. 2003;170:2106–2112. PubMed

Flodström-Tullberg M, Yadav D, Hägerkvist R, Tsai D, Secrest P, Stotland A, et al. Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse. Diabetes. 2003;52:2696–2700. PubMed

Fujii H. Mechanisms of signal transduction from receptors of type I and type II cytokines. J Immunotoxicol. 2007;4:69–76. PubMed

Gadient RA, Otten UH. Interleukin-6 (IL-6) – a molecule with both beneficial and destructive potentials. Progr Neurobiol. 1997;52:379–390. PubMed

Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, et al. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem. 1995;232:54–61. PubMed

Gallagher DC, Bhatt RS, Parikh SM, Patel P, Seery V, McDermott DF, et al. Angiopoietin 2 is a potential mediator of high-dose interleukin 2-induced vascular leak. Clin Cancer Res. 2007;13:2115–2120. PubMed

Ganz T, Nemeth E. Regulation of iron acquisition and iron distribution in mammals. Biochim Biophys Acta. 2006;1763:690–699. PubMed

Gardner B, Zu LX, Sharma S, Liu Q, Makriyannis A, Tashkin DP, et al. Autocrine and paracrine regulation of lymphocyte CB2 receptor expression by TGF-β. Biochem Biophys Res Commun. 2002;290:91–96. PubMed

Gaspari AA. Mechanism of action and other potential roles of an immune response modifier. Cutis. 2007;79(Suppl.)(4):36–45. PubMed

Gazzaniga S, Bravo AI, Guglielmotti A, van Rooijen N, Maschi F, Vecchi A, et al. Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft. J Invest Dermatol. 2007;127:2031–2041. PubMed

Genovese MC. Biologic therapic in clinical development for the treatment of rheumatoid arthritis. J Clin Rheumatol. 2005;11(Suppl.)(3):S45–S54. PubMed

Gerli R, Bistoni O, Russano A, Fiorucci S, Borgato L, Cesarotti ME, et al. In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease. Clin Exp Immunol. 2002;129:549–555. PubMed PMC

Gharaee-Kermani M, Phan SH. Role of cytokines and cytokine therapy in wound healing and fibrotic diseases. Curr Pharm Des. 2001;7:1083–1103. PubMed

Ghosh MC, Mondal AC, Basu S, Banerjee S, Majumder J, Bhattacharya D, et al. Dopamine inhibits cytokine release and expression of tyrosine kinases, Lck and Fyn in activated T cells. Int Immunopharmacol. 2003;3:1019–1026. PubMed

Giampietri A, Puccetti P, Contessa AR. Depression of hepatic biotransformations by chemical immunoadjuvants. J Immunopharmacol. 1981;3:251–264. PubMed

Gonzales AM, Orlando RA. Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutr Metab. 2008;12:17–29. PubMed PMC

Gorelik L, Prokhorova A, Mokyr MB. Low-dose melpharan-induced shift in the production of a Th2-type cytokine to a Th1-type cytokine in mice bearing a large MOPC-315 tumor. Cancer Immunol Immunother. 1994;39:117–126. PubMed

Gorski JC, Hall SD, Becker P, Affrime MB, Cutler DL, Haehner-Daniels B. In vivo effects of interleukin-10 on human cytochrome P450 activity. Clin Pharmacol Ther. 2000;67:32–43. PubMed

Gosselin J, Tomolu A, Gallo RC, Flamand L. Interleukin-15 as an activator of natural killer cell-mediated antiviral response. Blood. 1999;94:4210–4219. PubMed

Grande F, Garofalo A, Neamati N. Small molecules anti-HIV therapeutics targeting CXCR4. Curr Pharm Des. 2008;14:385–404. PubMed

Graziosi C, Pantaleo G, Gantt KR, Fortin JP, Demarest JF, Cohen OJ, et al. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science. 1994;265:248–252. PubMed

Gray PW, Aggarwal BB, Benton CV, Bringman TS, Henzel WJ, Jarrett JA, et al. Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activity. Nature. 1984;312:721–724. PubMed

Gröne A. Keratinocytes and cytokines. Vet Immunol Immunopathol. 2002;88:1–12. PubMed

Guarner F, Schaafsma GJ. Probiotics. Int J Food Microbiol. 1998;39:237–238. PubMed

Gullo VP, McAlpine J, Lam KS, Baker D, Petersen F. Drug discovery from natural products. J Ind Microbiol Biotechnol. 2006;33:523–531. PubMed

Gupta AK, Cherman AM, Tyring SK. Viral and nonviral uses of imiquimod: a review. J Cutan Med Surg. 2004;8:338–352. PubMed

Haas CS, Amin MA, Allen BB, Ruth JH, Haines GK, III, Woods JM, Koch AE. Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis. Arthritis Rheum. 2006;54:2402–2414. PubMed

Haas CS, Amin MA, Ruth JH, Allen BL, Ahmed S, Pakozdi A, et al. In vivo inhibition of angiogenesis by interleukin-13 gene therapy in a rat model of rheumatoid arthritis. Arthritis Rheum. 2007;56:2535–2548. PubMed

Hakonarson H, Maskeri N, Carter C, Grunstein MM. Regulation of TH1- and TH2-type cytokine expression and action in atopic asthmatic sensitized airway smooth muscle. J Clin Invest. 1999;103:1077–1087. PubMed PMC

Hameg A, Gouarin C, Gombert JM, Hong SM, VanKaer L, Bach JF, et al. IL−7 up-regulates IL-4 production by splenic NK1.1+ and NK1.1- MHC class I-like/CD1-dependent CD4+ T cells. J Immunol. 1999;162:7067–7074. PubMed

Hao J-S, Shan B-E. Immune enhancement and anti-tumour activity of IL-23. Cancer Immunol Immunother. 2006;55:1426–1431. PubMed PMC

Hartmann G, Kim H, Piquette-Miller M. Regulation of the hepatic multidrug resistance gene expression by endotoxin and inflammatory cytokines in mice. Int Immunopharmac. 2001;1:189–199. PubMed

Haskó G, Szabó C. Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system. Biochem Pharmacol. 1998;56:1079–1087. PubMed

Haskó G, Pacher P, Deitch EA, Vizi ES. Shaping of monocyte and macrophage function by adenosine. Pharmacol Ther. 2007;113:264–275. PubMed PMC

He B, You L, Uematsu K, Zang K, Xu Z, Lee AY, et al. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci U S A. 2003;100:14133–14138. PubMed PMC

Heim MH. The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus. J Recept Signal Transduct Res. 1999;19:75–120. PubMed

Hendeles L, Asmus M, Chesrown S. Evaluation of cytokine modulators for asthma. Paediatr Respir Rev. 2004;5(Suppl. A):S107–S112. PubMed

Herath KB, Jayasuriya H, Ondeyka JG, Polishook JD, Bills GF, Dombrowski AW, et al. Isolation and structures of novel fungal metabolites as chemokine receptor (CCR2) antagonists. J Antibiot (Tokyo) 2005;58:686–694. PubMed

Higa S, Hirano T, Kotani M, Matsumoto M, Fujita A, Suemura M, et al. Fisetin, a flavonol, inhibits TH2-type cytokine production by activated human basophils. J Allergy Clin Immunol. 2003;111:1299–1306. PubMed

Hirano T, Higa S, Arimitsu J, Naka T, Shima Y, Ohshima S, et al. Flavonoids such as luteolin, fisetin and apigenin are inhibitors of interleukin-4 and interleukin-13 production by activated human basophils. Int Arch Allergy Immunol. 2004;134:135–140. PubMed

Hoesl CE, Altwein JE. The probiotic approach: an alternative treatment option in urology. Eur Urol. 2005;47:288–296. PubMed

Holgate ST, Polosa R. Treatment strategies for allergy and athma. Nature Rev. 2008;8:218–230. PubMed

Hommes DW, Mikhajlova TL, Stoinov S, Stimac D, Vucelic B, Lonovics J, et al. Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease. Gut. 2006;55:1131–1137. PubMed PMC

Hong J-H, Yu ES, Han A-R, Nam J-W, Seo E-K, Hwang ES. Isoleutherin and eleutherinol, naturally occuring selective modulators of Th cell-mediated immune responses. Biochem Biophys Res Commun. 2008;371:278–282. PubMed

Horrigan LA, Kelly JP, Connor TJ. Immunomodulatory effects of caffeine: friend or foe? Pharmacol Ther. 2006;111:877–892. PubMed

Houshmand P, Zlotnik A. Therapeutic applications in the chemokine superfamily. Curr Opin Chem Biol. 2003;7:457–460. PubMed

Howard OM, Ben-Baruch A, Oppenheim JJ. Chemokines: progress toward identifying molecular targets for therapeutic agents. Trends Biotechnol. 1996;14:46–51. PubMed

Huang S, Mills L, Mian B, Tellez C, McCarty M, Yang XD, et al. Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol. 2002;161:125–134. PubMed PMC

Idzko M, la Sala A, Ferrari D, Panther E, Herouy Y, Dichmann S, et al. Expression and function of histamine receptors in human monocyte-derived dendritic cells. J Allergy Clin Immunol. 2002;109:839–846. PubMed

Imada K, Leonard WJ. The Jak-STAT pathway. Mol Immunol. 2000;37:1–11. PubMed

Imanaka K, Tamura S, Fukui K, Ito N, Kiso S, Imai Y, et al. Enhanced expression of suppressor of cytokine signalling-1 in the liver of chronic hepatitis C: possible involvement in resistance to interferon therapy. J Viral Hepat. 2005;12:130–138. PubMed

Ioannou Y, Isenberg DA. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. Arthritis Rheum. 2000;43:1431–1442. PubMed

Isaacs A, Lindenmann J. Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci. 1957;147:258–264. PubMed

Islam M, Frye RF, Richards TJ, Sbeitan I, Donnelly SS, Glue P, et al. Differential effect of IFNα–2b on the cytochrome P450 enzyme system: a potential basis of IFN toxicity and its modulation by other drugs. Clin Cancer Res. 2002;8:2480–2487. PubMed

Jan TR, Farraj AK, Harkema JR, Kaminski NE. Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice. Toxicol Appl Pharmacol. 2003;188:24–35. PubMed

Jan TR, Su ST, Wu HY, Liao MH. Suppressive effects of cannabidiol on antigen-specific antibody production and functional activity of splenocytes in ovalbumin-sensitized BALB/c mice. Int Immunopharmacol. 2007;7:773–780. PubMed

Jover R, Bort R, Gómez-Lechón MJ, Castell JV. Down-regulation of human CYP3A4 by the inflammatory signal interleukin-6: molecular mechanism and transcription factors involved. FASEB J. 2002;16:1799–1801. PubMed

Kaiko GE, Horvat JC, Beagley KW, Hansbro PM. Immunological decision-making: how does the immune system decode to mount a helper T-cell response? Immunology. 2008;122:326–338. PubMed PMC

Kalliomäki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet. 2003;361:1869–1871. PubMed

Kalsotra A, Anakk S, Brommer CL, Kikuta Y, Morgan ET, Strobel HW. Catalytic characterization and cytokine mediated regulation of cytochrome P450 4Fs in rat hepatocytes. Arch Biochem Biophys. 2007;461:104–112. PubMed PMC

Kandimalla ER, Bhagat L, Li Y, Yu D, Wang D, Cong YP, et al. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2′-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists. Proc Natl Acad Sci U S A. 2005;102:6925–6930. PubMed PMC

Katiyar SK. UV-induced immune suppression and photocarcinogenesis: chemoprevention by dietary botanical agents. Cancer Lett. 2007;255:1–11. PubMed PMC

Katona S, Kaminski E, Sanders H, Zajicek J. Cannabinoid influence on cytokine profile in multiple sclerosis. Clin Exp Immunol. 2005;140:580–585. PubMed PMC

Kelly-Welch AE, Hanson EM, Boothby MR, Keegan AD. Interleukin-4 and interleukin-13 signaling connections maps. Science. 2003;300:1527–1528. PubMed

Kero J, Gissler M, Hemminki E, Isolauri E. Could TH1 and TH2 diseases coexist? Evaluation of asthma incidence in children with coeliac disease, type 1 diabetes, or rheumatoid arthritis: a register study. J Allergy Clin Immunol. 2001;108:781–783. PubMed

Khan IA. Issues related to botanicals. Life Sci. 2006;78:2033–2038. PubMed

Kidd P. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern Med Rev. 2003;8:223–246. PubMed

Kihara T, Umesue I, Soeda S, Toda A, Ono N, Shigematsu H, et al. Hepatic heme metabolism in rats with fever induced by interleukin 1beta. Res Commun Mol Pathol Pharmacol. 1999;104:115–126. PubMed

Kile BT, Alexander WS. The suppressors of cytokine signalling (SOCS) Cell Mol Life Sci. 2001;58:1627–1635. PubMed PMC

Kim J, Modlin RL, Moy RL, Dubinett SM, McHugh T, Nickoloff BJ, et al. IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response. J Immunol. 1995;155:2240–2247. PubMed

Kim YS, Jung DH, Kim NH, Lee YM, Kim JS. Effect of magnolol on TGF-beta1 and fibronectin expression in human retinal pigment epithelial cells under diabetic conditions. Eur J Pharmacol. 2007;562:12–19. PubMed

Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res. 2008;79:360–376. PubMed PMC

Klein TW, Newton C, Larsen K, Lu L, Perkins I, Nong L, et al. The cannabinoid system and immune modulation. J Leukoc Biol. 2003;74:486–496. PubMed

Kmonícková E, Melkusová P, Harmatha J, Vokác K, Farghali H, Zídek Z. Inhibitor of sarco-endoplasmic reticulum Ca2+-ATPase thapsigargin stimulates production of nitric oxide and secretion of interferon-gamma. Eur J Pharm. 2008;588:85–92. PubMed

Krebs DL, Hilton DJ. SOCS proteins: negative regulators of cytokine signaling. Stem Cells. 2001;19:378–387. PubMed

Krieg AM. Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Disc. 2006;5:471–484. PubMed

Kroemer G, Wick G. The role of interleukin 2 in autoimmunity. Immunol Today 1989. 1989;10:246–251. PubMed

Krouwels FH, Hol BEA, Lutter R, Bruinier B, Bast A, Jansen HM, et al. Histamine affects interleukin-4, interleukin-5, and interferon-γ production by human T cell clones from the airways and blood. Am J Respir Cell Mol Biol. 1998;18:721–730. PubMed

Kühlwein E, Irwin M. Melatonin modulation of lymphocyte proliferation and Th1/Th2 cytokine expression. J Neuroimmunol. 2001;117:51–57. PubMed

Kuhn CF, Bazin M, Philippe L, Zhang J, Tylaska L, Miret J, et al. Bipiperidinyl carboxylic acid amides as potent, selective, and functionally active CCR4 antagonists. Chem Biol Drug Des. 2007;70:268–272. PubMed

La Cava A, Sarvetnick N. The role of cytokines in autoimmunity. Curr Dir Autoimmun. 1999;1:56–71. PubMed

Lavon I, Sheinin T, Meilin S, Biton E, Weksler A, Efroni G, et al. A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation. Mol Pharmacol. 2003;64:1334–1341. PubMed

Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet. 2000;356:2144–2148. PubMed

Lee J, Chuang T-H, Redecke V, She L, Pitha PM, Carson DA, et al. Molecular basis for the stimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7. Proc Natl Acad Sci U S A. 2003;100:6646–6651. PubMed PMC

Lee JY, Kim JY, Lee YG, Shin WC, Chun T, Rhee MH, et al. Hydroquinine, a reactive metabolite of benzene, reduces macrophage-mediated immune responses. Mol Cells. 2007;23:198–206. PubMed

Leeson GA, Biedenbach SA, Chan KY, Gibson JP, Wright GJ. Decrease in the activity of the drug-metabolizing enzymes of rat liver following the administration of tilorone hydrochloride. Drug Metab Dispos. 1976;4:232–238. PubMed

Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, Renauld JC. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct from IL-10. J Biol Chem. 2002;277:33676–33682. PubMed

Levine SJ. Mechanisms of soluble cytokine receptor generation. J Immunol. 2004;173:5343–5348. PubMed

Levings MK, Sangregorio R, Galbiati F, Squadrone S, de Waal Malefyt R, Roncarolo M-G. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells. J Immunol. 2001;166:5530–5539. PubMed

Lewis DB. Allergy immunotherapy and inhibition of Th2 immune responses: a sufficient strategy? Curr Opin Immunol. 2002;14:644–651. PubMed

Li H, Sim TC, Alam R. IL-13 released by and localized in human basophils. J Immunol. 1996;156:4833–4838. PubMed

Li MO, Wan YY, Sanjabi S, Robertson A-KL, Flavell RA. Transforming growth factor-β regulation of immune responses. Annu Rev Immunol. 2006;24:99–146. PubMed

Ligresti A, Moriello AS, Starowicz K, Matias I, Pisanti S, De Petrocellis L, et al. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. J Pharmacol Exp Ther. 2006;318:1375–1387. PubMed

Lipsky PE. Interleukin-6 and rheumatic diseases. Arthr Res Ther. 2006;8(Suppl.)(2):S4–S8. PubMed PMC

Lit LC, Wong CK, Li EK, Tam LS, Lam CW, Lo YM. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus. J Rheumatol. 2007;34:89–96. PubMed

Liu F, Ng TB, Fung MC. Pineal indoles stimulate the gene expression of immunomodulating cytokines. J Neural Transm. 2001;108:397–405. PubMed

Liu H, Leung BP. CD4+CD25+ regulatory T cells in health and disease. Clin Exp Pharmacol Physiol. 2006;33:519–524. PubMed

Liu KD, Gaffen SL, Goldsmith MA. JAK/STAT signaling by cytokine receptors. Curr Opin Immunol. 1998;10:271–278. PubMed

Loisel-Meyer S, Foley R, Medin JA. Immuno-gene therapy approaches for cancer: from in vitro studies to clinical trials. Front Biosci. 2008;13:3202–3214. PubMed

Lorentz A, Schwenberg S, Mierke C, Manns MP, Bischoff SC. Human intestinal mast cells produce IL-5 in vitro upon IgE receptor cross-linking and in vivo in the course of intestinal inflammatory disease. Eur J Immunol. 1999;29:1496–1503. PubMed

Machida K, Mayer BJ. The SH2 domain: versatile signaling module and pharmaceutical target. Biochim Biophys Acta. 2005;1747:1–25. PubMed

Mantovani A. The chemokine system: redundancy for robust outputs. Immunol Today. 1999;20:254–257. PubMed

Marciano BE, Wesley R, De Carlo ES, Anderson VL, Barnhart LA, Darnell D, et al. Long-term interferon-γ therapy for patients with chronic granulomatous disease. Clin Infect Dis. 2004;39:692–699. PubMed

Markus M, Moisés M, Klaus E, Manuel M. Murine macrophages secrete interferon? upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J Exp Med. 1998;187:2103–2109. PubMed PMC

Marshall JK. Ilodecakin. Schering-Plough Corp. IDrugs. 1999;2:1045–1058. PubMed

Massi P, Vaccani A, Paloralo D. Cannabinoids, immune system and cytokine network. Curr Pharm Des. 2006;12:3135–3146. PubMed

McDermott JR, Humphreys NE, Forman SP, Donaldson DD, Grencis RK. Intraepithelial NK cell-derived IL-13 induces intestinal pathology associated with nematode infection. J Immunol. 2005;175:3207–3213. PubMed

McInnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol. 2007;7:429–442. PubMed

Meyer AL, Elmadfa I, Herbacek I, Micksche M. Probiotic, as well as conventional yogurt, can enhance the stimulated production of proinflammatory cytokines. J Hum Nutr Diet. 2007;20:590–598. PubMed

Middel P, Lippert U, Hummel KM, Bertsch HP, Artuc M, Schweyer S, et al. Expression of lymphotoxin-alpha by keratinocytes: a further mediator for the lichenoid reaction. Pathobiology. 2000;68:291–300. PubMed

Miettinen M, Matikainen S, Vuopio-Varkila J, Pirhonen J, Varkila K, Kurimoto M, et al. Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect Immun. 1998;66:6058–6062. PubMed PMC

Miles BA, Lafuse WP, Zwilling BS. Binding of alpha-adrenergic receptors stimulates the anti-mycrobacterial activity of murine peritoneal macrophages. J Neuroimmunol. 1996;71:19–24. PubMed

Mirolo M, Fabbri M, Sironi M, Vecchi A, Guglielmotti A, Mangano G, et al. Impact of the anti-inflammatory agent bindarit on the chemokinome: selective inhibition of the monocyte chemotactic proteins. Eur Cytokine Netw. 2008;19:119–122. PubMed

Miwa M, Kozawa O, Tokuda H, Uematsu T. Mitogen-activated protein (MAP) kinases are involved in interleukin-1 (IL-1)-induced IL-6 synthesis in osteoblasts: modulation not of p38 MAP kinase, but of p42/p44 MAP kinase by IL-1-activated protein kinase C. Endocrinology. 1999;140:5120–5125. PubMed

Miyazaki Y, Yokozeki H, Awad S, Igawa K, Minatohara K, Satoh T, et al. Glucocorticoids augment the chemically induced production of gene expression of interleukin-1β through NF-κB and AP-1 activation in murine epidermal cells. J Invest Dermatol. 2000;115:746–752. PubMed

Miyazawa K, Shinozaki M, Hara T, Furuya T, Miyazono K. Two major Smad pathways in TGF-β superfamily signalling. Genes Cells. 2002;7:1191–1204. PubMed

Miyoshi M, Nadai M, Nitta A, Ueyama J, Shimizu A, Takagi K, et al. Role of tumor necrosis factor-alpha in down-regulation of hepatic cytochrome P450 and P-glycoprotein by endotoxin. Eur J Pharmacol. 2005;507:229–237. PubMed

Mizuno T, Sawada M, Marunouchi T, Suzumura A. Production of interleukin-10 by mouse glial cells in culture. Biochem Biophys Res Commun. 1994;205:1907–1915. PubMed

Mizutani T, Masuda M, Nakai E, Furumiya K, Togawa H, Nakamura Y, et al. Genuine functions of P-glycoprotein (ABCB1) Curr Drug Metab. 2008;9:167–174. PubMed

Mohagheghpour N, Waleh N, Garger SJ, Dousman L, Grill LK, Tusé D. Synthetic melanin suppresses production of proinflammatory cytokines. Cell Immunol. 2000;199:25–36. PubMed

Möhle R, Salemi P, Moore MA, Rafii S. Expression of interleukin-5 by human bone marrow microvascular endothelial cells: implications for the regulation of eosinophilopoiesis in vivo. Br J Haematol. 1997;99:732–738. PubMed

Molet S, Hamid Q, Davoine F, Nutku E, Taha R, Pagé N, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol. 2001;108:420–438. PubMed

Moqbel R, Ying S, Barkans J, Newman TM, Kimmitt P, Wakelin M, et al. Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J Immunol. 1995;155:4939–4947. PubMed

Mosmann TR, Coffman RL. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145–174. PubMed

Müller GF, Döhr O, El-Bahay C, Kahl R, Abel J. Effect of transforming growth factor-beta1 on cytochrome P450 expression: inhibition of CYP1 mRNA and protein expression in primary rat hepatocytes. Arch Toxicol. 2000;74:145–152. PubMed

Muntané-Relat J, Ourlin JC, Domergue J, Maurel P. Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology. 1995;22:1143–1153. PubMed

Murreille E, Leo O. Revisiting the Th1/Th2 paradigm. Scand J Immunol. 1998;47:1–9. PubMed

Nadin L, Butler AM, Farrell GC, Murray M. Pretranslational down-regulation of cytochromes P450 2C11 and 3A2 in male rat liver by tumor necrosis factor alpha. Gastroenterology. 1995;109:198–205. PubMed

Nakamura A, Johns EJ, Imaizumi A, Yanagawa Y, Kohsaka T. Effect of β2-adrenoceptor activation and angiotensin II on tumour necrosis factor and interleukin 6 gene transcription in the rat renal resident macrophage cells. Cytokine. 1999;11:759–765. PubMed

Nalbandian G, Kovats S. Understanding sex biases in immunity: effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol Res. 2005;31:91–106. PubMed

Newton CA, Lu T, Nazian SJ, Perkins I, Friedman H, Klein TW. The THC-induced suppression of Th1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2. J Leukoc Biol. 2004;76:854–861. PubMed

Nitta T, Ebato M, Sato K, Okumura K. Expression of tumor necrosis factor-α,, -β and interferon-γ genes within human neuroglial tumor cells and brain specimens. Cytokine. 1994;6:171–180. PubMed

Numasaki M, Watanabe M, Suzuki T, Takahashi H, Nakamura A, McAllister F, et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J Immunol. 2005;175:6177–6189. PubMed

O'Garra A, Vieira P. TH1 cells control themselves by producing interleukin-10. Nat Rev Immunol. 2007;7:425–428. PubMed

O'Garra A, Chang R, Hastings R, Go N, Haughton G, Howard M. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin-10. Eur J Immunol. 1992;22:711–717. PubMed

O'Hara AM, O'Regan P, Fanning A, O'Mahony C, Macsharry J, Lyons A, et al. Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology. 2006;118:202–215. PubMed PMC

Onuffer JJ, Horuk R. Chemokines, chemokine receptors and small-molecule antagonists: recent developments. TIPS. 2002;23:459–467. PubMed

Openshaw P, Murphy EE, Hosken NA, Maino V, Davis K, Murphy K, et al. Heterogenity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 popoulations. J Exp Med. 1995;182:1357–1367. PubMed PMC

Oppenheim JJ, Murphy WJ, Chertov O, Schirrmacher V, Wang JM. Prospects for cytokine and chemokine biotherapy. Clin Cancer Res. 1997;3:2682–2686. PubMed

Owen C. Chemokine receptors in airway disease: which receptors to target? Pulm Pharmac Therap. 2001;14:193–202. PubMed

Packard KA, Khan MM. Effects of histamine on Th1/Th2 cytokine balance. Int Immunopharmac. 2003;3:909–920. PubMed

Pageaux GP, Ie Bricquir Y, Berthou F, Bressot N, Picot MC, Blanc F, et al. Effects of interferon-alpha on cytochrome P-450 isoforms 1A2 and 3A activities in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol. 1998;10:491–495. PubMed

Pang Y, Norihisa Y, Benjamin D, Kantor RRS, Young HA. Interferon-γ-gene expression in human B-cell lines: induction by interleukin-2, protein kinase C activators, and possible effect of hypomethylation on gene regulation. Blood. 1992;80:724–732. PubMed

Panitch HS, Hirsch RL, Haley AS, Johnson KP. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet. 1987;1:893–895. PubMed

Patwardhan B, Gautam M. Botanical immunomodulators: scope and opportunities. Drug Discov Today. 2005;10:495–502. PubMed PMC

Paul AT, Gohil VM, Bhutani KK. Modulating TNF-α signaling with natural products. Drug Discov Today. 2006;11:725–732. PubMed

Paul C, Seiliez I, Thissen JP, LeCam A. Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids. Eur J Biochem. 2000;267:5849–5857. PubMed

Pease JE. Asthma, allergy and chemokines. Curr Drug Targ. 2006;7:3–12. PubMed

Peraldi P, Filloux C, Emanuelli B, Hilton DJ, Van Obberghen E. Insulin induces suppressor of cytokine signaling-3 tyrosine phosphorylation through janus-activated kinase. J Biol Chem. 2001;276:24614–24620. PubMed

Perez GM, Melo M, Keegan AD, Zamorano J. Aspirin and salicylates inhibit the IL-4- and IL-13-induced activation of STAT6. J Immunol. 2002;168:1428–1434. PubMed

Perry CM, Jarvis B. Peginterferon-alpha-2a (40 kD): a review of its use in the management of chronic hepatitis C. Drugs. 2001;61:2263–2288. PubMed

Perry CM, Wilde MI. Interferon-alpha-2a: a review of its use in chronic hepatitis C. BioDrugs. 1998;10:65–89. PubMed

Perussia B. Lymphokine-activated killer cells, natural killer cells and cytokines. Curr Opin Immunol. 1991;3:49–55. PubMed

Petray PB, Rottenberg ME, Bertot G, Corral RS, Diaz A, Orn A, et al. Effect of anti-γ-interferon and anti-interleukin-4 administration on the resistance of mice against infection with reticulotropic and myotropic strains of Trypanosoma cruzi. Immunol Lett. 1993;35:77–80. PubMed

Pinkas J, Teicher BA. TGF-β in cancer and as a therapeutic target. Biochem Pharmacol. 2006;72:523–529. PubMed

Prandota J. Important role of proinflammatory cytokines/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections/inflammation states, and genetic polymorphisms of drug-metabolizing enzymes/cytokines may markedly contribute to this pathology. Am J Ther. 2005;12:254–261. PubMed

Puddu P, Fais S, Luciani F, Gherardi G, Dupuis ML, Romagnoli G, et al. Interferon-gamma up-regulates expression and activity of P-glycoprotein in human peripheral blood monocyte-derived macrophages. Lab Invest. 1999;79:1299–1309. PubMed

Puffenbarger RA, Boothe AC, Cabral GA. Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia. 2000;29:58–69. PubMed

Pugh-Humphreys RGP, Thomson AW. Cytokines and their receptors as potential therapeutic targets. In: Thomson AW, editor. The Cytokine Handbook. 3rd. San Diego: Academic Press; 1998. pp. 885–951.

Raduner S, Majewska A, Chen JZ, Xie XQ, Hamon J, Faller B, et al. Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects. J Biol Chem. 2006;281:14192–14206. PubMed

Raghavendra V, Singh V, Kulkarni SK, Agrewala JN. Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists. Mol Cell Biochem. 2001;221:57–62. PubMed

Rachmawati H, Reker-Smit C, Lub-de Hooge MN, van Loenen-Weemaes A, Poelstra K, Beljaars L. Chemical modification of interleukin-10 with mannose 6-phosphate groups yields a liver-selective cytokine. Drug Metab Dispos. 2007;35:814–821. PubMed

Ratcliffe MJ, Walding A, Shelton PA, Flaherty A, Dougall IG. Activation of E-prostanoid4 and E-prostanoid2 receptors inhibits TNF-alpha release from human alveolar macrophages. Eur Respir J. 2007;29:986–994. PubMed

Ricci A, Mariotta S, Amenta F, Tayebati SK, Terzano C. Changes in muscarinic cholinergic receptor expression in human peripheral blood lymphocytes in allergic rhinitis patients. Pulm Pharmacol Ther. 2008;21:79–87. PubMed

Richards DF, Fernandez M, Caulfield J, Hawrylowicz CM. Glucocorticoids drive human CD8+ T cell differentiation towards a phenotype with high IL-10 and reduced IL-4, IL-5 and IL-13 production. Eur J Immunol. 2000;30:2344–2354. PubMed

Robbins MS, Mannering GJ. Effects of the interferon inducing agents tilorone and polyriboinosinic acid . polyribocytidylic acid (poly IC) on the hepatic monooxygenase systems of pregnant and fetal rats. Biochem Pharmacol. 1984;33:1213–1222. PubMed

Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol. 1994;12:227–257. PubMed

Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev. 2006;212:28–50. PubMed

Rönnblom L, Eloranta ML, Alm GV. The type I interferon system in systemic lupus erythematosus. Arthritis Rheum. 2006;54:408–420. PubMed

Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol. 2000;18:217–242. PubMed

Saavedra J. Probiotics and infectious diarrhea. Am J Gastroenterol 95. 2000;1(Suppl.):S16–S18. PubMed

Sacerdote P, Martucci C, Vaccani A, Bariselli F, Panerai AE, Colombo A, et al. The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro. J Neuroimmunol. 2005;159:97–105. PubMed

Salvi S, Semper A, Blomberg A, Holloway J, Jaffar Z, Papi A, et al. Interleukin-5 production by human airway epithelial cells. Am J Respir Cell Mol Biol. 1999;20:984–991. PubMed

Sandborn WJ. How future tumor necrosis factor antagonists and other compounds will meet the remaining challenges in Crohn's disease. Rev Gastroenterol Disord. 2004;4(Suppl.)(3):S25–S33. PubMed

Saunders J, Tarby CM. Opportunities for novel therapeutic agents acting at chemokine receptors. Drug Discov Today. 1999;4:80–91. PubMed

Sawada M, Imamura K, Nagatsu T. Role of cytokines in inflammatory process in Parkinson's disease. J Neural Transm. 2006;70(Suppl.):373–381. PubMed

Schindler H, Diefenbach A, Rollinghoff M, Bogdan C. IFN-γ inhibits the production of latent transforming growth factor-β1 by mouse inflammatory macrophages. Eur J Immunol. 1998;28:1181–1188. PubMed

Schmidinger M, Hejna M, Zielinski CC. Aldesleukin in advanced renal cell carcinoma. Exp Rev Anticancer Ther. 2004;4:957–980. PubMed

Schwarz MK, Wells TNC. Interfering with chemokine networks – the hope for new therapeutics. Curr Opin Chem Biol. 1999;3:407–417. PubMed

Seidel HM, Lamb P, Rosen J. Pharmaceutical intervention in the JAK/STAT signaling pathway. Oncogene. 2000;19:2645–2656. PubMed

Seki Y, Inoue H, Nagata N, Hayashi K, Fukuyama S, Matsumoto K, et al. SOCS-3 regulates onset and maintenance of TH2-mediated allergic responses. Nat Med. 2003;9:1047–1054. PubMed

Shalaby MR, Waage A, Espevik T. Cytokine regulation of interleukin 6 production by human endothelial cells. Cell Immunol. 1989;121:372–382. PubMed

Shida K, Suzuki T, Kiyoshima-Shibata J, Shimada S, Nanno M. Essential roles of monocytes in stimulating human peripheral blood mononuclear cells with Lactobacillus casei to produce cytokines and augment natural killer cell activity. Clin Vaccine Immunol. 2006;13:997–1003. PubMed PMC

Shimbara A, Christodoulopoulos P, Soussi-Gounni A, Olivenstein R, Nakamura Y, Levitt RC, et al. IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol. 2000;105:108–115. PubMed

Shin HC, Benbernou N, Fekkar H, Esnault S, Guenounou M. Regulation of IL-17, IFN-γ and IL-10 in human CD8+ T cells by cyclic AMP-dependent signal transduction pathway. Cytokine. 1998;10:841–850. PubMed

Shinkai M, Henke MO, Rubin BK. Macrolide antibiotics as immunomodulatory medications: proposed mechanisms of action. Pharmacol Ther. 2008;117:393–405. PubMed

Shtrichman R, Samuel CE. The role of gamma interferon in antimicrobial immunity. Curr Opin Microbiol. 2001;4:251–259. PubMed

Silvennoinen O, Saharinen P, Paukku K, Takaluoma K, Kovanen P. Cytokine receptor signal transduction through Jak tyrosine kinases and Stat transcription factors. APMIS. 1997;105:497–509. PubMed

Singh G, Renton KW, Stebbing N. Homogeneous interferon from E. coli depresses hepatic cytochrome P-450 and drug biotransformation. Biochem Biophys Res Commun. 1982;106:1256–1261. PubMed

Sitaraman SV, Gewirtz AT. Oprelvekin. Genetics Institute. Curr Opin Investig Drugs. 2001;2:1395–1400. PubMed

Song JS, HaleemSmith H, Arudchandran R, Gomez J, Scott PM, Mill JF, et al. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway. J Immunol. 1999;163:802–810. PubMed

Spellberg B, Edwards JEJ. Type 1/type 2 immunity in infectious diseases. Clin Infect Dis. 2001;32:76–102. PubMed

Spelman K, Burns J, Nichols D, Winters N, Ottersberg S, Tenborg M. Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators. Altern Med Rev. 2006;11:128–150. PubMed

Srivastava MD, Srivastava BI, Brouhard B. Delta9 tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells. Immunopharmacology. 1998;40:179–185. PubMed

Strizki JM, Tremblay C, Xu S, Wojcik L, Wagner N, Gonsiorek W, et al. Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1. Antimicrob Agents Chemother. 2005;49:4911–4919. PubMed PMC

Su HC, Cousens LP, Fast LD, Slifka MK, Bungiro RD, Ahmed R, et al. CD4+ and CD8+ T cell interactions in IFN-gamma and IL-4 responses to viral infections: requirements for IL-12. J Immunol. 1998;160:5007–5017. PubMed

Suárez-Méndez R, García-García I, Fernández-Olivera N, Valdés-Quintana M, Milanés-Virelles MT, Carbonell D, et al. Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study. BMC Infect Dis. 2004;4:44–51. PubMed PMC

Subramanian GM, Fiscella M, Lamousé-Smith A, Zeuzem S, McHutchison JG. Albinterferon alpha-2b: a genetic fusion protein for the treatment of chronic hepatitis C. Nat Biotechnol. 2007;25:1411–1419. PubMed

Sukhai M, Yong A, Pak A, Piquette-Miller M. Decreased expression of P-glycoprotein in interleukin-1beta and interleukin-6 treated rat hepatocytes. Inflamm Res. 2001;50:362–370. PubMed

Swiatecka-Urban A. Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status. Paediatr Drugs. 2003;5:699–716. PubMed

Szczuciński A, Losy J. Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies. Acta Neurol Scand. 2007;115:137–146. PubMed

Takahashi N, Kitazawa H, Iwabuchi N, Xiao JZ, Miyaji K, Iwatsuki K, et al. Immunostimulatory oligodeoxynucleotide from Bifidobacterium longum suppresses Th2 immune responses in a murine model. Clin Exp Immunol. 2006;145:130–138. PubMed PMC

Takeuchi T, Ueki T, Sasaki Y, Kajiwara T, Li B, Moriyama N, et al. Th2-like response and antitumor effect of anti-interleukin-4 mAb in mice bearing renal cell carcinoma. Cancer Immunol Immunother. 1997;43:375–381. PubMed PMC

Tambur AR, Markham PN, Gebel HM. IL-4 inhibits P-glycoprotein in normal and malignant NK cells. Hum Immunol. 1998;59:483–487. PubMed

Tapner M, Liddle C, Goodwin B, George J, Farrell GC. Interferon gamma down-regulates cytochrome P450 3A genes in primary cultures of well-differentiated rat hepatocytes. Hepatology. 1996;24:367–373. PubMed

Tarkowski E. Cytokines in dementias. Curr Drug Targets Inflamm Allergy. 2002;1:193–200. PubMed

Tayebati SK, Amenta F, Amici S, El-Assouad D, Gallai V, Ricci A, et al. Peripheral blood lymphocytes muscarinic cholinergic receptor subtypes in Alzheimer's disease: a marker of cholinergic dysfunction? J Neuroimmunol. 2001;121:126–131. PubMed

Theofilopoulos AN, Koundouris S, Kono DH, Lawson BR. The role of IFN-γ in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity. Arhritis Res. 2001;3:136–141. PubMed PMC

Thomsen LL, Topley P, Daly MG, Brett SJ, Tite JP. Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery. Vaccine. 2004;22:1799–1809. PubMed

Tinel M, Elkahwaji J, Robin MA, Fardel N, Descatoire V, Haouzi D, et al. Interleukin-2 overexpresses c-myc and down-regulates cytochrome P-450 in rat hepatocytes. J Pharmacol Exp Ther. 1999;289:649–655. PubMed

Tsuji F, Oki K, Okahara A, Suhara H, Yamanouchi T, Sasano M, et al. Differential effects between marimastat, a TNF-alpha converting enzyme inhibitor, and anti-TNF-alpha antibody on murine models for sepsis and arthritis. Cytokine. 2002;17:294–300. PubMed

Umannová L, Machala M, Topinka J, Nováková Z, Milcová A, Kozubík A, et al. Tumor necrosis factor-alpha potentiates genotoxic effects of benzo[a]pyrene in rat liver epithelial cells through upregulation of cytochrome P450 1B1 expression. Mutat Res. 2008;640:162–169. PubMed

Verthelyi D, Ishii KJ, Gursel M, Takeshita F, Klinman DM. Human peripheral blood cells differentially recognize and respond to two distinst CpG motifs. J Immunol. 2001;166:2372–2377. PubMed

Verzijl D, Storelli S, Scholten DJ, Bosch L, Reinhart TA, Streblow DN, et al. Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors. J Pharmacol Exp Ther. 2008;325:544–555. PubMed PMC

Vilček J. The cytokines: an overview. In: Thomson AW, Lotze MT, editors. The Cytokine Handbook. 4th edn. Vol. 1. Amsterdam: Academic Press; 2003. pp. 3–18.

Vincent JL. Afelimomab. Int J Clin Pract. 2000;54:190–193. PubMed

Vinderola G, Matar C, Palacios J, Perdigón G. Mucosal immunomodulation by the non-bacterial fraction of milk fermented by Lactobacillus helveticus R389. Int J Food Microbiol. 2007;115:180–186. PubMed

Vlotides G, Sörensen AS, Kopp F, Zitzmann K, Cengic N, Brand S, et al. SOCS-1 and SOCS-3 inhibit IFN-alpha-induced expression of the antiviral proteins 2,5-OAS and MxA. Biochem Biophys Res Commun. 2004;320:1007–1014. PubMed

von Patay B, Loppnow H, Feindt J, Kurz B, Mentlein R. Catecholamines and lipopolysaccharide synergistically induce the release of interleukin-6 from thymic epithelial cells. J Neuroimmunol. 1998;86:182–189. PubMed

Voravud N, Sriuranpong V. Clinical benefits of epoetin alfa (Eprex) 10 000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy. J Med Assoc Thailand. 2005;88:607–612. PubMed

Vugmeyster Y, Szklut P, Tchistiakova L, Abraham W, Kasaian M, Xu X. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of humanized monoclonal anti-IL-13 antibodies with different IL-13 neutralization mechanisms. Int Immunopharmacol. 2008;8:477–483. PubMed

Vuppugalla R, Shah RB, Chimalakonda AP, Fisher CW, Mehvar R. Microsomal cytochrome P450 levels and activities of isolated rat livers perfused with albumin. Pharm Res. 2003;20:81–88. PubMed

de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries J. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10-produced by monocytes. J Exp Med. 1991;174:1209–1220. PubMed PMC

Wagner TL, Ahonen CL, Couture AM, Gibson SJ, Miller RL, Smith RM, et al. Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod. Cell Immunol. 1999;191:10–19. PubMed

Waller EK. The role of sargramostim (rhGM-CSF) as immunotherapy. Oncologist. 2007;12(Suppl.)(2):22–26. PubMed

Wang CH, Gao ZQ, Ye B, Cai JT, Xie CG, Qian KD, et al. Effect of emodin on pancreatic fibrosis in rats. World J Gastroenterol. 2007;13:378–382. PubMed PMC

Wang Q, Miyakawa Y, Fox N, Kaushansky K. Interferon-α directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1. Blood. 2000;96:2093–2099. PubMed

Warren HS, Kinnear BF, Phillips JH, Lanier LL. Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12. J Immunol. 1995;154:5144–5152. PubMed

Welters ID, Menzebach A, Goumon Y, Langefeld TW, Teschemacher H, Hempelmann G, et al. Morphine suppresses complement receptor expression, phagocytosis, and respiratory burst in neutrophils by a nitric oxide and µ3 opiate receptor-dependent mechanism. J Neuroimmunol. 2000;111:139–145. PubMed

Werb Z, Foley R, Munck A. Interaction of glucocorticoid receptors on monocytes and macrophages. J Exp Med. 1978;147:1684–1694. PubMed PMC

Whitehouse MW, Beck FJ. Impaired drug metabolism in rats with adjuvant-induced arthritis: a brief review. Drug Metab Dispos. 1973;1:251–255. PubMed

Wick MJ, Minnerath SR, Roy S, Ramakrishan S, Loh HH. Differential expression of opioid receptor genes in human lymphoid cell lines and peripheral blood lymphocytes. J Neuroimmunol. 1996;64:29–36. PubMed

Williams K, Dooley N, Ulvestad E, Becher B, Antel JP. IL-10 production by adult human derived microglial cells. Neurochem Int. 1996;29:55–64. PubMed

Wittig BM. Drug evaluation: CNTO-1275, a mAb against IL-12/IL-23p40 for the potential treatment of inflammatory diseases. Curr Opin Investig Drugs. 2007;8:947–954. PubMed

Wolk K, Sabat R. Interleukin-22: a novel T- and NK-cell derived cytokine that regulates the biology of tissue cells. Cytokine Growth Factor Rev. 2006;17:367–380. PubMed

Wrana JL, Attisano L, Wieser R, Ventura F, Massagué J. Mechanism of activation of TGF-β receptor. Nature. 1994;370:341–347. PubMed

Wu R, Cui X, Dong W, Zhou M, Simms HH, Wang P. Suppression of hepatocyte CYP1A2 expression by Kupffer cells via AhR pathway: the central role of proinflammatory cytokines. Int J Mol Med. 2006;18:339–346. PubMed

Wybran J, Appelboom T, Famaey J-P, Govaerts A. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood T lymphocytes. J Immunol. 1979;123:1068–1070. PubMed

Xing Z, Wang J. Consideration of cytokines as therapeutics agents or targets. Curr Pharmaceut Design. 2000;6:599–611. PubMed

Yanagita M, Shimabukuro Y, Nozaki T, Yoshimura N, Watanabe J, Koide H, et al. IL-15 up-regulates iNOS expression and NO production by gingival epithelial cells. Biochem Biophys Res Commun 2002. 2002;297:329–334. PubMed

Yang GB, Qiu CL, Zhao H, Liu Q, Shao Y. Expression of mRNA for multiple serotonin (5-HT) receptor types/subtypes by the peripheral blood mononuclear cells of rhesus macaques. J Neuroimmunol. 2006;178:24–29. PubMed

Yasukawa H, Sasaki A, Yoshimura A. Negative regulation of cytokine signaling pathways. Annu Rev Immunol. 2000;18:143–164. PubMed

Yin TG. Characterization of IL-6 production by B-cells. Immunol Invest. 1990;19:413–420. PubMed

Ying S, Durham SR, Corrigan CJ, Hamid Q, Kay AB. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects. Am J Respir Cell Mol Biol. 1995;12:477–487. PubMed

Ying S, O'Connor BJ, Meng Q, Woodman N, Greenaway S, Wong H, et al. Expression of prostaglandin E2 receptor subtypes on cells in sputum from patients with asthma and controls: effect of allergen inhalational challenge. J Allergy Clin Immunol. 2004;114:1309–1316. PubMed

Yoshimura A, Naka T, Kubo K. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol. 2007;7:454–465. PubMed

Youn HS, Saitoh SI, Miyake K, Hwang DH. Inhibition of homodimerization of Toll-like receptor 4 by curcumin. Biochem Pharmacol. 2006;72:62–69. PubMed

Yu JJ, Gaffen SL. Interleukin-17: a novel inflammatory cytokine that brdges innate and adaptive immunity. Front Biosci. 2008;13:170–177. PubMed

Yu P, Zheng C, Chen J, Zhang G, Liu Y, Suo X, et al. Investigation on PEGylation strategy of recombinant human interleukin-1 receptor antagonist. Bioorg Med Chem. 2007;15:5396–5405. PubMed

Zhang Y, Center DM, Wu DM, Cruikshank WW, Yuan J, Andrews DW, et al. Processing and activation of pro-interleukin-16 by caspase-3. J Biol Chem. 1998;273:1144–1149. PubMed

Zhang Y, Hegen M, Xu J, Keith JCJ, Jin G, Du X, et al. Characterization of (2R, 3S)-2-([[4-(2-butynyloxy)phenyl]sulfonyl]amino)-N,3-dihydroxybutanamide, a potent and selective inhibitor of TNF-alpha converting enzyme. Int Immunopharmacol. 2004;4:1845–1857. PubMed

Zhou H, Jang H, Fleischmann RM, Bouman-Thio E, Xu Z, Marini JC, et al. Pharmacokinetics and safety of golimumab, a fully human anti-TNF-alpha monoclonal antibody, in subjects with rheumatoid arthritis. J Clin Pharmacol. 2007;47:383–396. PubMed

Zhu HJ, Burgess AW. Regulation of transforming growth factor-β signaling. Mol Cell Biol Res Commun. 2001;4:321–330. PubMed

Zhu LX, Sharma S, Stolina M, Gardner B, Roth MD, Tashkin DP, et al. Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunol. 2000;165:373–380. PubMed

Zídek Z. Adenosine – cyclic AMP pathways and cytokine expression. Eur Cytokine Netw. 1999;10:319–328. PubMed

The role of the microbiome and psychosocial stress in the expression and activity of drug metabolizing enzymes in mice